AGOPTON caps 15 mg 14 pce
7680519690492
CH-51969
A02BC03
04.99.0.
1 / 3
google
Details
- Product number
- 5196902
- CPT
- -
- Packaging group
- 14
- Unit
- Kapsel(n)
- Composition
- lansoprazolum 15 mg, magnesii subcarbonas ponderosus, sacchari sphaerae, saccharum, maydis amylum, hydroxypropylcellulosum substitutum humile, hydroxypropylcellulosum, acidi methacrylici et ethylis acrylatis polymerisati 1:1 dispersio 30 per centum cum natrii laurilsulfas, macrogolum 8000, E 171, polysorbatum 80, talcum, silica colloidalis anhydrica, Kapselhülle: gelatina, aqua, E 171, pro capsula corresp. natrium max. 0.02 mg et saccharum max. 80.3 mg.
Articles (1)
Agopton 15 mg, magensaftresistente Hartkapseln
Magensaftresistente Hartkapseln
14
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 15.40
Specialties list
Yes
Generic
No
SL addition date:
15/03/1996
Authorization holder
Takeda Pharma AG
8152 Opfikon
Authorization information
- Swissmedic authorization number
- 51969
- Drug name
- Agopton, magensaftresistente Hartkapseln
- Galenic form
- KAHAM
- ATC Code
- A02BC03
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 18/06/1993
- Authorization expiration date
- 31/12/9999
- IT number
- 04.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AGOPTON caps 15 mg 14 pce
- Description (DE)
- AGOPTON Kaps 15 mg 14 Stk
- Market launch
- 11/09/1995
- Narcotic (BTM)
- No